ELCC 2014 European Lung Cancer Conference

The European Lung Cancer Conference (ELCC), is the most important conference in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.

It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.

Fast facts: ELCC 2014

  • Over 1400 international participants expected
  • Specialists and key opinion leaders from all over the world in one place and as one community
  • Two key note lectures and 14 educational sessions running over four days
  • An internationally-renowned faculty
  • Seven Industry Satellite Symposia
  • Vibrant commercial exhibition
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution the following organisations have made to the ELCC conferences over the years.

Past attendees

Abbott Laboratories

Agennix

Astrazeneca

Bayer Schering Pharma

Boehringer Ingelheim

Cis Bio International

Daiichi Sankyo Europe

Eli Lilly

Elsevier

GE Healthcare

GSK

Karl Storz

Merck Serono

Microsulis Medical Ltd.

MSD

Novartis Oncology

Olympus Medical Systems Europe

Pfizer Oncology

Qiagen

Roche

Rosetta Genomics

Sanofi

Varian Medical Systems

How can I participate in ELCC 2014?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our conferences.

Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings